|
|
|
| Application of Human Body Composition Monitor Analysis in Patients with Maintenance Hemodialysis |
| DONG Guan-nan, WANG Kai, YANG Yu-peng, et al |
| Nutriology Department Hebei Provincial People's Hospital 1 Shijiazhuang, Hebei Province 050061) |
|
|
|
|
Abstract 【Objective】To explore the application value of human body composition monitor test in maintenance hemodialysis (MHD) patients. 【Methods】A total of 70 patients with MHD in our hospital were selected and randomly divided into the observation group (n=36) and the control group (n=34). Patients in the observation group received human body composition analysis and targeted-nutrition and health guidance, while patients in the control group received routine nutrition and health education. The serum albumin, pre-albumin and other related parameters in both groups before and after treatment were measured. 【Results】After treatment, the albumin, prealbumin and total protein in the observation group were (39.82±5.44) g/L, (290.78±35.1) mg/L and (67.15 ±12.23) g/L, respectively, which were significantly higher than those in the control group(36.12±5.20)g/L,(266.21±36.40)mg/L and (55.41±11.84)g/L, respectively (P<0.05), while the water ratio in the observation group was (0.37±0.06), which was significantly lower than that in the control group(0.40±0.05) (P<0.05). The serum creatinine, serum phosphorus and calcium-phosphorus multiplier scores in the observation group after treatment were (310.34±90.53) mmol/L, (1.20 ±0.32) mmol/L and (30.49±5.29) mg2/dl2,respectively, which were significantly lower than those in the control group (420.11±99.82)mmol/L,(1.71±0.31)mmol/L and(38.56±6.11)mg2/dl2 (P<0.05), respectively; while serum calcium in the observation group was significantly higher than that in the control group (P<0.05). After treatment, the PG-SGA score of the observation group was (1.87±0.43), which was significantly lower than that of the control group (2.98±0.67)(P<0.05). 【Conclusion】Human body composition monitor has a good application value in MHD patients, which can effectively improve nutritional status of patients.
|
|
Received: 27 May 2019
|
|
|
|
|
|
[1] 刘方芳,郭硕,高淑清.生物电阻抗分析法(BIA)在评估维持性血液透析患者营养状况中的应用[J].营养学报,2017,39(4):411-413.
[2] 唐俊,左满花. 血液透析联合血液灌流对尿毒症患者透析效率、脂代谢及动脉粥样硬化的影响[J].海南医学院学报,2017,23(4):497-500.
[3] 张席军,安文军,周淑娟,等.慢性肾脏病患者外周血 FGF-23水平与钙磷代谢的相关性分析[J].湖南师范大学学报(医学版),2016,13(4):52-54.
[4] 王建爽,王艳辉,杨文艳,等.生物电阻抗分析仪和N末端脑钠肽前体在维持性血液透析患者容量负荷与心功能评估中的应用[J].中国医学装备,2016,13(9):77-80.
[5] 张瑜凌.维持性血液透析患者饮食蛋白摄入与营养状况的相关研究[J].中华肾脏病杂志,2016,32(3):161-166.
[6] 常美香,董梅,黄丽雅,等.维持性血液透析患者不同透析龄营养状况的评价[J].国际泌尿系统杂志,2016,36(2):229-232.
[7] 达静静,王松,林鑫,等.维持性血液透析患者静息能量代谢率与人体测量参数的相关性[J].中华肾脏病杂志,2018,34(4):261-266.
[8] 李杰,张启蒙,卢亚梅,等. 应用生物电阻抗法评估维持性血液透析患者透析不同时间点血压与体液分布的关系[J].中国血液净化,2016,15(8):401-406.
[9] 余毅,刘书凤,王琰,等.维持性血液透析患者人体成分分析评估营养状况[J].中国血液净化,2016,15(6):353-356.
[10] 田滨瑶,张惠娟,韩怡然,等.人体成分监测仪对长期血液透析患者干体质量的评估[J].中国血液净化,2018,17(4):234-237. |
| [1] |
. [J]. JOURNAL OF CLINICAL RESEARCH, 2020, 37(8): 1267-1268. |
|
|
|
|
2020, Vol. 37 
